Topical Treatment Patents (Class 514/887)
  • Patent number: 7351747
    Abstract: A method for treating skin itch in an individual in need of such treatment, by topically administering an amount effective for relieving said itch of an additive selected from the group consisting of (a) aluminum chlorohydrates; (b) aluminum zirconium chlorohydrates; (c) chlorohydrates of aluminum and aluminum zirconium, each complexed with polyalkylene glycol; (d) chlorohydrates of aluminum and aluminum zirconium, wherein in each of said chlorohydrates some of the water of hydration has been replaced by glycine; (e) aluminum chloride hydrate; and mixtures thereof. In particular, a spray comprising aluminum chlorohydrate aqueous composition is applied to the affected surface area of the skin to effect relief from itching.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: April 1, 2008
    Inventor: Gilbert Buchalter
  • Patent number: 7341746
    Abstract: This application relates to a material which is suitable for the treatment of atopic disease, non-atopic eczema or psoriasis. The material can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebouriella, Fructus Tribuli, Herba Potentilla chinensis, Caulis Clematis armandii, Radix Rehmannia, Radix Glycyrrhiza, Radix Paeonia rubra, Cortex Dictamni radicis, Herba Lopatheri, Spica Schizonepetae. The material comprises one or more of those components present in the freeze-dried decoction which run with Rf values in the ranges 0.00 to 0.100, 0.167 to 0.300, 0.400 to 0.533, 0.700 to 0.833 or 0.900 to 0.967 if the freeze-dried decoction is diluted in aqueous solution and subjected to chromatography on a Whatman 2 cms×55 cms×3 mm cellulose strip for 10 hours using a solvent mixture of butanol, ethanol and water in the proportions 4:1:1.
    Type: Grant
    Filed: November 20, 2003
    Date of Patent: March 11, 2008
    Assignee: Phytotech Limited
    Inventors: Brian Anthony Whittle, Jonathan Brostoff, Yvette Latchman
  • Patent number: 7332470
    Abstract: The use of collectins and/or surfactant proteins for the treatment and prevention of ocular disease.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: February 19, 2008
    Assignees: The Regents of the University of California, The Research Foundation of State University of New York
    Inventors: Suzanne Fleiszig, David J. Evans, Robert Sack
  • Patent number: 7329423
    Abstract: A thylakoid extract that is preferably stabilized and activable for treating inflammation is described. Different types of cell or tissue targets and inflammatory stimuli have been used to evaluate the performance of the extract, which, in all cases successfully modulate inflammation through a balance of pro/anti-inflammatory cytokines. Compositions comprising the extract and other anti-inflammatory agents, such as glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs) are further disclosed and claimed.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: February 12, 2008
    Assignee: Purecell Technologies Inc.
    Inventors: Alain Andersen, Elyse Bissonnette, Rejean Drouin, Marc Purcell
  • Patent number: 7314634
    Abstract: A composition is provided to treat and/or prevent for treating skin conditions including fine lines and wrinkles, acne rosacea, surface irregularities of the skin and hyper-pigmentation melasma of the skin, which includes use of a topically applied composition such as an ointment, lotion, cream, serum, gel or pad applied formulation, containing an effective amount of polyphenols, such as green tea based polyphenols, including but not limited to catechins, such as epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicathechin 3-gallate (ECG) and epicatechin (EC). The formulation is preferably composed of 90 percent polyphenol isolates, derived from green tea with potent antioxidant properties, to assist in minimizing free-radical induced skin damage.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: January 1, 2008
    Inventors: Steven Hernandez, Burt Shaffer
  • Patent number: 7309688
    Abstract: Described are skin-care compositions containing non denatured soy products and optionally other anti-cancer or anti-aging agents. The compositions can be applied topically to reduce the risk of UV-induced cutaneous tumors.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: December 18, 2007
    Assignees: Johnson & Johnson Consumer Companies, Rutgers, The State University of New Jersey
    Inventors: Miri Seiberg, Stanley S. Shapiro, Christine Paine, Allan H. Conney, Mou-Tuan Huang
  • Patent number: 7300666
    Abstract: The present invention relates to the discovery of a transdermal delivery system that can deliver high molecular weight pharmaceuticals and cosmetic agents to skin cells. A novel transdermal delivery system with therapeutic and cosmetic application and methods of use of the foregoing is disclosed.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: November 27, 2007
    Assignee: JRX Biotechnology, Inc.
    Inventor: Frederick L. Jordan
  • Patent number: 7276255
    Abstract: Super-oxidized water based on hypochlorous acid, such as is obtained by the electrochemical treatment of a saline solution, may be used in the treatment of leg ulcers or other open wounds. Preferably, the pH of the super-oxidized water is in a range of 4 to 7, and the water has a redox potential of >950 mV. Medicaments based on the super-oxidized water may be in liquid or gel form. The super-oxidized water is able to control the microbial population within the wound and at the same time permit cell proliferation.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: October 2, 2007
    Assignee: Sterilox Medical (Europe) Limited
    Inventor: Joe B. Selkon
  • Patent number: 7262179
    Abstract: Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The composition may be in sprayable form or dispersed in an aqueous solution. Methods of making and using the compositions are also described.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: August 28, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Andrew D. Court, David D. Kershaw
  • Patent number: 7238680
    Abstract: A method of treating a non-human dermatological disorder, wherein the method comprises topically administering to a non-human dermatological disorder a therapeutically effective amount of a topical composition containing: (1) an active component comprising at least one salicylate derivative; and (2) at least one pharmaceutically acceptable solubilizer.
    Type: Grant
    Filed: June 3, 2002
    Date of Patent: July 3, 2007
    Inventor: Steven E. Rosen
  • Patent number: 7201919
    Abstract: The present invention relates to the discovery of a transdermal delivery system that can deliver high molecular weight pharmaceuticals and cosmetic agents to skin cells. A novel transdermal delivery system with therapeutic and cosmetic application and methods of use of the foregoing is disclosed.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: April 10, 2007
    Inventor: Frederick L. Jordan
  • Patent number: 7198800
    Abstract: Non-aerosol spray-on skin patch compositions as described comprising at least one substantially water insoluble film forming agent, at least one film plasticizer agent, at least one water soluble compound, and at least one organic solvent, the composition forming a flexible, porous and physiologically compatible skin patch when sprayed on to skin and allowed to dry. Also described are methods of improving wound healing by administering a physiologically active ingredient to a patient in need of such treatment.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: April 3, 2007
    Inventor: Thomas Sai Ying Ko
  • Patent number: 7186755
    Abstract: The present invention relates to nimesulide topical formulations comprising a carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and a solvent selected from the group consisting of ethanol, isopropanol and diethylene glycol monoethyl ether, and to the process for the preparation thereof. Said formulations have advantages such as higher stability of the system and bioavailability of the active ingredient.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: March 6, 2007
    Assignee: Helsinn Health Care S.A.
    Inventors: Stefano Bader, Enrique Häusermann, Tiziana Monti
  • Patent number: 7147864
    Abstract: The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline.
    Type: Grant
    Filed: March 23, 2004
    Date of Patent: December 12, 2006
    Assignee: Somerset Pharmaceuticals, Inc.
    Inventor: Mark G. Resnick
  • Patent number: 7115273
    Abstract: A soothing anti-viral lotion composition and a lotioned tissue product having a surface with the lotion composition applied thereto, and methods for making and using the same. The lotion composition includes an anti-viral organic acid and a topical delivery system. The topical delivery system includes one or more polyesters which allow incorporation of the organic acids into the lotion formulation, controls their delivery, and maintains them in the stratum corneum. The lotion composition may optionally contain a surfactant, an irritation inhibiting agent, and other additives.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: October 3, 2006
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Gary L. Shanklin, Duane G. Krzysik, Cynthia W. Henderson
  • Patent number: 7097860
    Abstract: A method of reducing inflammation in a variety of disorders by using an intraperitoneal solution of magnesium. The solution can be used for treating inflammatory and inflammation-related disorders in animals and/or humans. Application of the solution reduces inflammation and thereby assists in the healing process. An alternative method involves the intraperitoneal administration of a solution containing magnesium salts. Another alternative method provides for treatment of inflammatory and inflammation-related disorders in animals by way of intraperitoneal administration of a solution containing magnesium salts, methenamine or its salts and dextrose. The method further provides the use of methenamine or its salts and/or dextrose in combination with magnesium.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: August 29, 2006
    Inventors: Aaron Moshenyat, Anna Moshenyat, Reuven Moshenyat, Yitzchak Moshenyat
  • Patent number: 7097861
    Abstract: This invention relates to a method of treating a livestock footbath solution comprising adding an alkali metal bisulfate to the solution. The invention also relates to a method of treating a livestock footbath solution comprising adding to the solution a blend of an alkali metal bisulfate and a material to treat a bacterial disease. The invention also relates to a method of treating a livestock footbath solution comprising rotating the addition to the solution of an alkali metal bisulfate and a material to treat a bacterial disease.
    Type: Grant
    Filed: February 5, 2004
    Date of Patent: August 29, 2006
    Assignee: Jones-Hamilton Co.
    Inventor: Michael Christopher O'Brien
  • Patent number: 7094431
    Abstract: This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound healing composition alone. In one embodiment, the wound healing composition comprises (a) zinc oxide; (b) calcium channel blocker, and (c) fat-soluble vitamins admixed with antibacterial and antifungal agents. The therapeutic antibacterial/antifungal-wound healing compositions may be utilized in a wide variety of pharmaceutical products and administered orally or topically.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: August 22, 2006
    Inventor: Mickey L. Peshoff
  • Patent number: 7087249
    Abstract: The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infection of the mucosal membrane. The antimicrobial metal may be formulated as, or used in the form of, a nanocrystalline coating of one or more antimicrobial or noble metals, a nanocrystalline powder of one or more antimicrobial or noble metals, or a liquid or solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial or noble metals.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: August 8, 2006
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert Edward Burrell, Antony George Naylor, Peter Howard Moxham
  • Patent number: 7078060
    Abstract: Solutions and aerosols of metal-containing compounds are disclosed. Methods of preparing and using the solutions and aerosols, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: July 18, 2006
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert E. Burrell, John B. Wright, Kan Lam, Hua Qing Yin, Antony G. Naylor, Peter H. Moxham, Scott H. Gillis, Paul Schechter
  • Patent number: 7029704
    Abstract: The anti-itch solution is a solution of hydrogen peroxide, sodium bicarbonate and apple cider vinegar applied to feet to prevent a common fungal infection of feet known as “athlete's foot”.
    Type: Grant
    Filed: December 29, 2003
    Date of Patent: April 18, 2006
    Inventor: Clifford E. Woods, Jr.
  • Patent number: 7029706
    Abstract: The inventions relates to the use of silica in the formulation of antifungal composition for the treatment of cutaneous mycoses, and method to manufacture an antifungal powder with boric acid and silica.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: April 18, 2006
    Inventor: Carlos Alberto Marrodan
  • Patent number: 7029663
    Abstract: A substantially anhydrous stable ointment containing Aspirin which is characterized in using gelation hydrocarbon and/or vaseline as a base. The ointment is superior in stability and can be stored for a long term.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: April 18, 2006
    Assignee: Teikoku Seiyaku Co., Ltd.
    Inventors: Noriko Mizobuchi, Yuichi Hasegawa, Mitsuhiro Kawada, Shin-ichi Hisaichi
  • Patent number: 7029659
    Abstract: A topical mousse composition including an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: January 27, 2004
    Date of Patent: April 18, 2006
    Assignee: Connetics Australia Pty Ltd.
    Inventor: Albert Zorko Abram
  • Patent number: 7018661
    Abstract: Aluminum-zirconium compounds applied topically, usually in a cream, gel, or other base, to lesions caused by any strain or type of Herpes simplex virus in humans and in other animals, will lessen the symptoms of the lesions, speed their healing, and possibly make the recurrence of such lesions less likely.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: March 28, 2006
    Inventor: Joseph G. Montes
  • Patent number: 7014871
    Abstract: An iodine preparation composition suitable for use on wounds comprising an iodide source, an oxidant and a buffer characterized in that the iodide is held separately from the oxidant until the point of use, and that the buffer is capable of maintaining the pH of the composition at between pH 45 and pH 6 so that iodine is generated at a physiologically acceptable dose rate.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: March 21, 2006
    Inventors: Dave Parsons, Elizabeth Jacques, Philip Bowler
  • Patent number: 7011854
    Abstract: Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases with a strong inflammatory component, such as atherosclerosis, stroke, coronary disease, and Alzheimers disease. The in vivo carbon monoxide-releasing compounds can be attached to known drug vectors and/or known anti-inflammatory drugs, such as aspirin.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: March 14, 2006
    Assignee: Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda
    Inventors: Werner Haas, Carlos Romao, Beatriz Roya, Ana Cristina Fernandes, Isabel Goncalves
  • Patent number: 7008647
    Abstract: The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of a acne. The nanocrystalline antimicrobial metal of choice may be used in the form of a nanocrystalline coating of one or more antimicrobial metals, a nanocrystalline powder of one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: March 7, 2006
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert Edward Burrell, Hua Qing Yin
  • Patent number: 6984667
    Abstract: Compositions with synergistic anti-inflammatory effect in inflammatory diseases resulting from activation and consequent degranulation of mast cell and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as chondroitin sulfate C and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, a special organic extra virgin kernel seed olive oil, S-adenosylmethionine and diphenhydramine.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: January 10, 2006
    Assignee: Theta Biomedical Consulting and Development Co.
    Inventor: Theoharis C. Theoharides
  • Patent number: 6979468
    Abstract: A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered in combination with zinc. The composition may also include quantities of copper and folic acid. In a most preferred embodiment, the nicotinamide and copper each are present in immediate release formats, while the zinc is present in a sustained release format.
    Type: Grant
    Filed: December 6, 2002
    Date of Patent: December 27, 2005
    Assignee: Sirius Laboratories
    Inventor: Frank Pollard
  • Patent number: 6979454
    Abstract: A biologically active stick composition comprising a biologically active agent dissolved in a carrier system including an unsaturated fatty acid alcohol in mutual dissolution with an alkylene glycol as a solvent for said biologically active agent and a stiffening agent therefor, said stiffening agent imparting stick consistency to the composition, said alkylene glycol preferably being present in an amount of more than 12%. The composition can be prepared by dissolving the active agent in the solvent, combining the solution with the stiffening agent and shaping the formulation into a stick. The composition is especially intended for use as a medicament, preferably in the treatment of dermatological conditions, where it has been found to possess outstanding bioavailability properties.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: December 27, 2005
    Assignee: Jagotec AG
    Inventors: Åke Lindahl, Rickard Bryland
  • Patent number: 6962720
    Abstract: The invention provides novel saponin mixtures and compounds which are isolated from the species Acacia victoriae and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: November 8, 2005
    Assignee: Research Development Foundation
    Inventors: Valsala Haridas, Jordan U. Gutterman
  • Patent number: 6958159
    Abstract: The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: October 25, 2005
    Assignee: Chiltern Pharmaceuticals, Pty Ltd.
    Inventor: Robert Alan Smith
  • Patent number: 6946145
    Abstract: Block copolymers based on poly(ortho esters) containing amine groups. These block copolymers have both hydrophilic and hydrophobic blocks. They form micelles in aqueous solution, making them suitable for encapsulation or solubilization of hydrophobic or water-insoluble materials; and they also form bioerodible matrices for the sustained release of active agents.
    Type: Grant
    Filed: July 24, 2003
    Date of Patent: September 20, 2005
    Assignee: A.P. Pharma, Inc.
    Inventors: Steven Y. Ng, Jorge Heller
  • Patent number: 6943197
    Abstract: Provided are methods and topical pharmaceutical formulations for the treatment of inflammatory dermatoses. The invention involves the topical administration of a pharmacologically active base in a formulation having a pH of about 7.5 to about 13.0, preferably about 8.0 to 11.5, and most preferably about 8.5 to 10.5. These basic formulations are particularly suited to the treatment of acne vulgaris.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: September 13, 2005
    Inventors: Howard I. Maibach, Eric C. Luo, Tsung-Min Hsu
  • Patent number: 6939568
    Abstract: The invention relates to the use of one or more antimicrobial metals, most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of inflammatory skin conditions. The nanocrystalline antimicrobial metal of choice may be used in the form of a nanocrystalline coating of one or more antimicrobial metals, a nanocrystalline powder of one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: September 6, 2005
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert Edward Burrell, Hua Qing Yin
  • Patent number: 6936288
    Abstract: A method and composition for treating herpes zoster varicella and related afflictions is provided. The method is achieved by diagnosing an individual affected with the herpes varicella zoster virus or related afflictions and applying a medicine to the affected area. The medicine comprises anti-viral proteins of a pokeweed plant.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: August 30, 2005
    Assignee: Klearsen Corporation
    Inventor: Steven R. Frank
  • Patent number: 6932966
    Abstract: A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatment mixture preferably additionally includes sodium benzoate to act as a preservative. A method of producing a skin treatment mixture includes the steps of providing a quantity of purified water; adding a quantity of sea salt to the quantity of purified water; boiling the purified water and sea salt; cooling the purified water and sea salt; adding a quantity of lysozyme to the purified water and sea salt; sterilizing the mixture and testing it for bacteria. A method of treating a pierced skin area includes the step of applying to the pierced area a reconstituted ocean water mixture of sea salt and lysozyme.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: August 23, 2005
    Inventor: Edward Kolos
  • Patent number: 6926913
    Abstract: The invention provides a composition of matter comprising molecular iodine and tetraglycol.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: August 9, 2005
    Assignees: Ben Gurion University of the Negev Research & Development Authority, Yissum Research Development Company of the Hebrew
    Inventors: Uri Wormser, Amnon Sintov
  • Patent number: 6921777
    Abstract: The invention relates to novel heteroethynylenic compounds having the general formula (I): as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and ophthalmological complaints in particular), or alternatively in cosmetic compositions.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: July 26, 2005
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Philippe Diaz, Jean-Michel Bernardon
  • Patent number: 6914051
    Abstract: A penetrating antibiotic gel for treating pain, inflammation and other pathological conditions affecting musculoskeletal tissues and other soft tissues of the body. The composition includes an antibiotic compound and a mobilizing agent in an amount sufficient to enable the antimicrobial compound to penetrate into the sub-dermal soft tissues. The antimicrobial compound may be a macrolide antibiotic compound such as azithromycin, erythromycin or roxithromycin, for example, and the mobilizing agent may be an organogel compound, such as pluronic lecithin liposomal organogel (PLO). The composition may further include a penetration enhancing adjuvant, such as d-limonene, for example. The composition may be applied topically so as to penetrate into the sub-dermal soft tissues, or may injected so as to be absorbed into the soft tissues locally.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: July 5, 2005
    Inventor: David M Allen
  • Patent number: 6911210
    Abstract: Use of cosmetic and/or dermatological preparations in the form of emulsions, comprising a) an effective amount of one or more ?-hydroxycarboxylic acids and/or an effective amount of one or more ?-hydroxycarboxylic acids b) one or more interface-active substances, chosen from the group of glucose derivatives and, if desired, furthermore comprising (c) one or more interface-active substances chosen from the group of oligoglycerides against blemished skin or acne.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: June 28, 2005
    Assignee: Beiersdorf AG
    Inventors: Angelika Bormann, Jens Nielsen, Andreas Herpens, Anja Müller, Jürgen Kielholz
  • Patent number: 6911436
    Abstract: The invention discloses the discovery that a pharmaceutical composition containing complex carbohydrates and natural or synthetic essential oils can work effectively as a topical pharmaceutical composition. Such pharmaceutical compositions reduce inflammation, assist in wound healing, protect against bruising, relieve itching, relieve pain and swelling and treat topical bacterial infections such as acne and decubitus ulcers. Such pharmaceutical compositions can be administered to mammals including humans. Also included in this invention are methods to deliver topically applied macromolecules into the tissue of mammals and methods of blocking the adhesion cascade.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: June 28, 2005
    Assignee: Dermal Reserach Laboratories, Inc.
    Inventors: Harold G. Brown, Karen K. Brown
  • Patent number: 6908625
    Abstract: The present invention concerns stabilized cosmetic material containing triple-encapsulated retinol. Unstable, fat-soluble retinol is stabilized firstly by addition into vesicles consisting of nonionic surface-active agent, cholesterol and cholesteryl ester. The firstly stabilized retinol(vesicle) is subsequently inserted into sphingosomes (a kind of multi lamellar liposome) consisting of lecithin and ceramide. Finally the double-encapsulated retinol (sphingosome) is inserted into lamellar liquid-crystal emulsifying base, thereby being triply encapsulated.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: June 21, 2005
    Assignee: Coreana Cosmetics Co., Ltd.
    Inventors: Seung Ji Lee, Byoung Kee Jo, Young Jin Lee, Chun Mong Lee
  • Patent number: 6905675
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: June 14, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans, Ray Figureoa
  • Patent number: 6905692
    Abstract: The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: June 14, 2005
    Assignee: Ganeden Biotech, Inc.
    Inventor: Sean Farmer
  • Patent number: 6906017
    Abstract: The bath product employs halite and a mixture of herbs and spices packed in water permeable bath bags to condition bath water and emit fragrances. The bath product includes five water permeable bags contained in an outer carrying bag. Four of the five water permeable bags contain the mixture and one contains halite. The mixture includes ground lemongrass, wrinkled skin lime, wrinkled skin lime leaves, holy basil, Zingiber cassumunar Roxb., and mint.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: June 14, 2005
    Inventors: Borie Pak Sonnergren, Ban Pak
  • Patent number: 6896909
    Abstract: The invention relates to formulations for the topical treatment of disorders with a bioenergetic basis, which contain a suspension obtainable by treating one or more iron ores with aqueous solutions having pH values of between 4 and 8. These formulations will be applied directly to the acupuncture points corresponding to the meridians involved in the conditions to be treated.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: May 24, 2005
    Assignee: GeoMedical S.r.l.
    Inventor: Mauro Fanelli
  • Patent number: 6881756
    Abstract: The present invention relates to a method for reducing inflammation in the skin and/or treating inflammatory skin disorders, pain, or pruritis by topically applying a composition comprising totarol or a pharmaceutically-acceptable ester thereof.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: April 19, 2005
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventor: Gerard J. Gendimenico
  • Patent number: 6875754
    Abstract: The invention relates to the use of water soluble ?-(1,3) glucans, which are essentially free from (1,6) links as active ingredients agents for producing therapeutic skin treatment agents. Said products strengthen the skin's immune system, counteract the formation of wrinkles and can be used to treat psoriasis and eczemic conditions.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: April 5, 2005
    Assignee: Biotec ASA
    Inventors: Ute Griesbach, Rolf Wachter, Achim Ansmann, Bernd Fabry, Rolf E. Engstad